Show simple item record

dc.contributor.authorShephard, EA
dc.contributor.authorHamilton, WT
dc.date.accessioned2018-08-14T10:30:03Z
dc.date.issued2018-08-14
dc.description.abstractBACKGROUND: Testicular cancer incidence has risen over the last two decades and is expected to continue to rise. There are no primary care studies on the clinical features of testicular cancer, with recent National Institute for Health and Care Excellence (NICE) guidance based solely upon clinical consensus. AIM: To identify clinical features of testicular cancer and to quantify their risk in primary care patients, with the aim of improving the selection of patients for investigation. DESIGN AND SETTING: A matched case-control study in males aged ≥17 years, using Clinical Practice Research Datalink records. METHOD: Putative clinical features of testicular cancer were identified and analysed using conditional logistic regression. Positive predictive values (PPVs) were calculated for those aged <50 years. RESULTS: In all, 1398 cases were available, diagnosed between 2000 and 2012, with 4956 age-, sex-, and practice-matched controls. Nine features were independently associated with testicular cancer, the top three being testicular swelling (odds ratio [OR] 280, 95% confidence interval [CI] = 110 to 690), testicular lump (OR 270, 95% CI = 100 to 740), and scrotal swelling (OR 170, 95% CI = 35 to 800). The highest PPV for 17-49-year-olds was testicular lump, at 2.5% (95% CI = 1.1 to 5.6). Combining testicular lump with testicular swelling or testicular pain produced PPVs of 17% and 10%, respectively. CONCLUSION: Testicular enlargement carries a risk of cancer of 2.5% - close to the current 3% threshold in UK referral guidance. Contrary to traditional teaching, painful testicular enlargement may signify cancer. Some initial hydrocele diagnoses appear to be wrong, with missed cancers, suggesting an ultrasound may be useful when a hydrocele diagnosis is uncertain. These results support the existing NICE guidelines, and help to characterise when an ultrasound should be considered in symptomatic men.en_GB
dc.description.sponsorshipFunding was provided by the Policy Research Unit in Cancer Awareness, Screening and Early Diagnosis. The views expressed in this paper are those of the authors and not necessarily those of the NHS, the Department of Health, or the Policy Research Unit, which receives funding for a research programme from the Department of Health Policy Research Programme. It is a collaboration between researchers from seven institutions (Queen Mary University of London, University College London [UCL], King’s College London, London School of Hygiene and Tropical Medicine, Hull York Medical School, Durham University, and University of Exeter Medical School).en_GB
dc.identifier.citationVol. 68, pp. e559 - e565en_GB
dc.identifier.doi10.3399/bjgp18X697949
dc.identifier.urihttp://hdl.handle.net/10871/33730
dc.language.isoenen_GB
dc.publisherRoyal College of General Practitionersen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/29970393en_GB
dc.rights.embargoreasonUnder embargo until 14 August 2019 in compliance with publisher policy.en_GB
dc.rights© 2018, British Journal of General Practiceen_GB
dc.subjectdiagnosisen_GB
dc.subjectlumpen_GB
dc.subjectpainen_GB
dc.subjectprimary health careen_GB
dc.subjecttesticular canceren_GB
dc.titleSelection of men for investigation of possible testicular cancer in primary care: a large case-control study using electronic patient recordsen_GB
dc.typeArticleen_GB
exeter.place-of-publicationEnglanden_GB
dc.descriptionThis is the author accepted manuscript. The final version is available from the Royal College of General Practitioners via the DOI in this record.en_GB
dc.identifier.journalBritish Journal of General Practiceen_GB
rioxxterms.versionAM
refterms.dateFCD2018-08-14T10:30:03Z
refterms.versionFCDVoR
refterms.dateFOA2019-08-14T00:00:00Z


Files in this item

This item appears in the following Collection(s)

Show simple item record